Vertex shareholders elect 11 directors, approve stock plan amendment adding 13.5M shares

VERTEX PHARMACEUTICALS INC / MA

All 11 director nominees elected, with Reshma Kewalramani receiving 218.7M votes for.
Ratification of Ernst & Young as auditor for FY2022 passed with 177.8M for, 51.9M against.
Advisory say-on-pay approved, 202.2M for vs 16.1M against.
Amendment to 2013 Stock and Option Plan adding 13.5M shares authorized for issuance approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.